We are now officially closer to the 2025 AGM than we are to the previous AGM.
It’s been a woeful 2025 so far by any metric IMO and the share price has fallen from 12 cents at last year’s AGM to 9 cents today.
The number of core objectives achieved as outlined in the May 2024 bad news dump webinar is ZERO.
Current cash balance today is likely to be approximately $15m only. Without a cash injection from a capital raising or from a significant cash up-front licencing deal, Starpharma risk going to the 2025 AGM in November with a tick above $10m in the bank.
I wonder if there will be yet another negative and unexpected surprise for long-suffering shareholders at this year’s AGM.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)